Product Overview

• 5-Fluorocytosine, known across medical and regulatory frameworks by its generic pharmacopoeial designation Flucytosine, is a fluorinated pyrimidine active pharmaceutical ingredient. Structurally, it features a cytosine ring network substituted with a fluorine atom at the position 5. It is commercially supplied as a brilliant white to off-white, odorless, uniform crystalline powder. ProCorBay International directs bulk supply lines of highly refined, premium-grade 5-Fluorocytosine to global generic drug manufacturing facilities, finished dosage formulation plants, and contract research organizations (CROs).
• 5-Fluorocytosine is manufactured through the precise chemical fluorination of cytosine intermediates or via the condensation of specialized fluorinated building blocks under optimized catalytic parameters, followed by rigorous aqueous recrystallization loops to remove unreacted precursors and trace elements. ProCorBay sources this active ingredient exclusively from advanced, GMP-certified production facilities tracking strict heavy metal profiles, organic volatile thresholds, and clean chromatographic profiles.
• Within the global healthcare sector, this compound represents a vital clinical active compound. Mechanistically, it functions as a highly selective antifungal countermeasure. Upon entering fungal cells via cytosine permease enzymes, it is rapidly converted into 5-fluorouracil, which incorporates into fungal RNA to disrupt protein translation and competitively inhibits thymidylate synthase to halt fungal DNA replication. It is widely leveraged by drug formulators to build oral capsules and intravenous infusion fluids targeting severe systemic mycoses. ProCorBay functions as a trusted bulk partner, providing full trace documentation and consistent material flows to guarantee predictable compounding performance.